{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T13:20:47Z","timestamp":1790256047994,"version":"4.1.0"},"reference-count":9,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1097\/coc.0b013e31827b45f9","type":"journal-article","created":{"date-parts":[[2013,1,25]],"date-time":"2013-01-25T11:55:07Z","timestamp":1359114907000},"page":"397-403","source":"Crossref","is-referenced-by-count":19,"title":["Axitinib for the Treatment of Metastatic Renal Cell Carcinoma"],"prefix":"10.1097","volume":"37","author":[{"given":"James","family":"Larkin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayer","family":"Fishman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Negrier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kara","family":"Olivier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Pyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera","family":"Gorbunova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Jonasch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lori","family":"Andrews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Staehler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R4-15-20210128","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2165\/11591240-000000000-00000","article-title":"Axitinib for the management of metastatic renal cell carcinoma.","volume":"11","author":"Escudier","year":"2011","journal-title":"Drugs R D"},{"key":"R12-15-20210128","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1177\/1078155207077335","article-title":"Chemotherapy induced diarrhea.","volume":"13","author":"Richardson","year":"2007","journal-title":"J Oncol Pharm Pract"},{"key":"R14-15-20210128","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1038\/sj.bjc.6603813","article-title":"Mechanisms of adverse effects of anti-VEGF therapy for cancer.","volume":"96","author":"Kamba","year":"2007","journal-title":"Br J Cancer"},{"key":"R17-15-20210128","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/S1548-5315(11)70751-3","article-title":"Managing the side effects of sorafenib and sunitinib.","volume":"3","author":"Wood","year":"2006","journal-title":"Commun Oncol"},{"key":"R19-15-20210128","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1056\/NEJMra0706547","article-title":"Chemotherapy-induced nausea and vomiting.","volume":"358","author":"Hesketh","year":"2008","journal-title":"N Engl J Med"},{"key":"R21-15-20210128","doi-asserted-by":"crossref","first-page":"227","DOI":"10.2165\/00002018-200326040-00003","article-title":"Benefits and risks of newer treatments for chemotherapy-induced and postoperative nausea and vomiting.","volume":"26","author":"Kovac","year":"2003","journal-title":"Drug Saf"},{"key":"R27-15-20210128","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1634\/theoncologist.2010-0078","article-title":"Fatigue in renal cell carcinoma: the hidden burden of current targeted therapies.","volume":"15","author":"Larkin","year":"2010","journal-title":"Oncologist"},{"key":"R31-15-20210128","doi-asserted-by":"crossref","first-page":"933","DOI":"10.6004\/jnccn.2010.0068","article-title":"Psychostimulants for cancer-related fatigue.","volume":"8","author":"Breitbart","year":"2010","journal-title":"J Natl Compr Canc Netw"},{"key":"R34-15-20210128","first-page":"636","article-title":"Tivozanib, a pan-VEGFR tyrosine kinase inhibitor for the potential treatment of solid tumors.","volume":"13","author":"De Luca","year":"2010","journal-title":"IDrugs"}],"container-title":["American Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/COC.0b013e31827b45f9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T00:09:19Z","timestamp":1620950959000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000421-201408000-00015"}},"subtitle":["Recommendations for Therapy Management to Optimize Outcomes"],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":9,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/coc.0b013e31827b45f9","relation":{},"ISSN":["0277-3732"],"issn-type":[{"value":"0277-3732","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]}}}